Reverse Transcriptase Inhibitors

All categories
DBCAT000594Pharmacologic class

Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. A DrugBank category of 34 drugs. 17 of them are approved.

Also known as
Inhibitors, Reverse Transcriptase
Drugs

and 9 more with a free account

What you can answer from here — as of August 24, 2016

34DrugsEach linked to its full drug card
Sign in
33Drug targetsEvery drug–target pair in the class, with bond type
Sign in
2,451Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
8Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Reverse Transcriptase Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In